Yubo International Biotech Limited
YBGJ · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Cost of Goods Sold | $44 | $45 | $45 | -$0 |
| Gross Profit | -$44 | -$45 | -$45 | -$0 |
| % Margin | – | – | – | 72.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $240 | $234 | $380 | $284 |
| SG&A Expenses | $240 | $234 | $380 | $284 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $27 | $16 | $87 | $73 |
| Operating Expenses | $267 | $250 | $467 | $357 |
| Operating Income | -$310 | -$250 | -$467 | -$357 |
| % Margin | – | – | – | 1,984,988.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $4 |
| Pre-Tax Income | -$310 | -$250 | -$467 | -$353 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$277 | -$230 | -$436 | -$290 |
| % Margin | – | – | – | 1,609,188.9% |
| EPS | -0.002 | -0.002 | -0.004 | -0.002 |
| % Growth | 0% | 47.2% | -50% | – |
| EPS Diluted | -0.002 | -0.002 | -0.004 | -0.002 |
| Weighted Avg Shares Out | 147,871 | 119,821 | 119,821 | 119,840 |
| Weighted Avg Shares Out Dil | 147,871 | 119,821 | 119,821 | 119,821 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $44 | $45 | $45 | $42 |
| EBITDA | -$267 | -$205 | -$423 | -$311 |
| % Margin | – | – | – | 1,725,672.2% |